Physician profile
Stacy Colson
NPI 1134913478
$912.58
in general payments reported to CMS, 2019-2025
16 companies · $913 in 2025
The $913 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $912.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calliditas Therapeutics US INC. | $148.61 | 2025 | Tarpeyo |
| Otsuka America Pharmaceutical, INC. | $145.01 | 2025 | Jynarque, Voyxact |
| Bayer Healthcare Pharmaceuticals INC. | $91.81 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.03 | 2025 | Jardiance |
| Shield Therapeutics INC | $85.41 | 2025 | |
| Fresenius USA Marketing, INC. | $76.59 | 2025 | Velphoro |
| Ani Pharmaceuticals, INC. | $68.48 | 2025 | Purified Cortrophin Gel |
| Opko Pharmaceuticals, LLC | $37.58 | 2025 | Rayaldee |
| Scpharmaceuticals INC. | $34.27 | 2025 | |
| Aurinia Pharma U.S., INC. | $21.08 | 2025 | Lupkynis |
| Travere Therapeutics, INC. | $20.86 | 2025 | |
| Pharmacosmos Therapeutics INC. | $19.30 | 2025 | Monoferric |
| Akebia Therapeutics INC | $18.72 | 2025 | Vafseo |
| Ardelyx, INC. | $18.44 | 2025 | Ibsrela |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $18.44 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.95 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Colson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.